Becton, Dickinson and Company (BDX)
Medical devices & diagnostics • Medication management systems • Infusion therapy • Diagnostic instruments (Kiestra, Veritor) • Biosciences & flow cytometry • C.R. Bard legacy (catheters, surgical) • Dividend Aristocrat 53yr
MOS 3.8%Upside 3.9%P/E 14.9Yield 2.71%ROE 14.4%
รายงาน →👁 0 · 👍 02026-08-18